Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06454604 · ClinicalTrials.gov registry record · Phase 3
Virtual Reality Treatment for Emerging Adults With ADHD
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT06454604 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 60 participants.
The verdict
NCT06454604, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this pilot randomized clinical trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.
Interventions
- BEHAVIORAL Meta Quest 3 VR Headset with noise cancelling headphones
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-07-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06454604
The ClinicalTrials.gov registry entry for NCT06454604 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meta Quest 3 VR Headset with noise cancelling headphones is the first listed.
NCT06454604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06454604 about?
NCT06454604 is a clinical study titled "Virtual Reality Treatment for Emerging Adults With ADHD". The goal of this pilot randomized clinical trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of ...
What is the current status of trial NCT06454604?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2024-09-20. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT06454604?
The interventions under investigation include: Meta Quest 3 VR Headset with noise cancelling headphones (BEHAVIORAL).
Who is sponsoring clinical trial NCT06454604?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.